JPS5865215A - 医薬組成物 - Google Patents

医薬組成物

Info

Publication number
JPS5865215A
JPS5865215A JP57153791A JP15379182A JPS5865215A JP S5865215 A JPS5865215 A JP S5865215A JP 57153791 A JP57153791 A JP 57153791A JP 15379182 A JP15379182 A JP 15379182A JP S5865215 A JPS5865215 A JP S5865215A
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
indomethacin
ranitidine
ibuprofen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP57153791A
Other languages
English (en)
Japanese (ja)
Inventor
アラン・シンクレア・マリオツト
アンドリユ−・ロ−ランド・マツケンジ−
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of JPS5865215A publication Critical patent/JPS5865215A/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP57153791A 1981-09-04 1982-09-03 医薬組成物 Pending JPS5865215A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB26786 1981-09-04
GB8126786 1981-09-04

Publications (1)

Publication Number Publication Date
JPS5865215A true JPS5865215A (ja) 1983-04-18

Family

ID=10524316

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57153791A Pending JPS5865215A (ja) 1981-09-04 1982-09-03 医薬組成物

Country Status (15)

Country Link
JP (1) JPS5865215A (it)
AU (1) AU564018B2 (it)
BE (1) BE894285A (it)
CH (1) CH652304A5 (it)
DE (1) DE3232830C2 (it)
FR (1) FR2512342B1 (it)
HK (1) HK91387A (it)
IE (1) IE54149B1 (it)
IT (1) IT1208432B (it)
KE (1) KE3739A (it)
MY (1) MY8700560A (it)
NL (1) NL193821C (it)
SE (1) SE8205034L (it)
SG (1) SG59387G (it)
ZA (1) ZA826477B (it)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01197444A (ja) * 1986-03-04 1989-08-09 Bristol Myers Co 非ステロイド系抗炎症組成物によって生じる消化管損傷に対するβ−アドレナリン作用薬とある種のヒスタミンH↓1−および/またはH↓2−受容体遮断薬との組合せの効果

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
AU627775B2 (en) * 1988-09-20 1992-09-03 Glaxo Group Limited Pharmaceutical compositions
CA2370268A1 (en) * 1999-04-19 2000-10-26 Richard Weisbart Treatment of adult rheumatoid arthritis by oral administration of pooled human immunoglobulin and an antacid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2360306A1 (fr) * 1976-08-03 1978-03-03 Huguet Georgette Nouveaux medicaments antalgiques, antiseptiques et anti-inflammatoires
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01197444A (ja) * 1986-03-04 1989-08-09 Bristol Myers Co 非ステロイド系抗炎症組成物によって生じる消化管損傷に対するβ−アドレナリン作用薬とある種のヒスタミンH↓1−および/またはH↓2−受容体遮断薬との組合せの効果

Also Published As

Publication number Publication date
HK91387A (en) 1987-12-11
FR2512342A1 (fr) 1983-03-11
DE3232830A1 (de) 1983-03-24
BE894285A (fr) 1983-03-02
IT8249071A0 (it) 1982-09-03
SE8205034L (sv) 1983-03-05
SG59387G (en) 1987-10-23
FR2512342B1 (fr) 1986-09-05
SE8205034D0 (sv) 1982-09-03
CH652304A5 (fr) 1985-11-15
DE3232830C2 (de) 1994-12-08
KE3739A (en) 1987-09-04
IT1208432B (it) 1989-06-12
NL193821C (nl) 2000-12-04
NL193821B (nl) 2000-08-01
NL8203457A (nl) 1983-04-05
MY8700560A (en) 1987-12-31
AU564018B2 (en) 1987-07-30
IE54149B1 (en) 1989-07-05
IE822152L (en) 1983-03-04
ZA826477B (en) 1984-04-25
AU8799782A (en) 1983-03-10

Similar Documents

Publication Publication Date Title
US5859060A (en) Timed release tablet comprising naproxen and pseudoepherine
GB2105193A (en) Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
US4757060A (en) Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 and H2, receptor blockers
US5037815A (en) Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 - and H2 -receptor blockers
RU2007126652A (ru) Композиции и способы стабилизации активных фармацевтических ингредиентов
RU99107283A (ru) Не содержащие лактозы, негигроскопичные и безводные фармацевтические препараты дескарбоэтоксилоратадина
CN101073563B (zh) 一种含有右旋布洛芬和左旋西替利嗪的手性组合物及其缓速释双层片
JP3874793B2 (ja) イブプロフェンおよびコデイン含有の改良された医薬処方
AP324A (en) Medicaments for treating inflammatory conditions or for analgiesia.
RU2005115883A (ru) Композиции с контролируемым высвобождением
FI117373B (fi) Parasetamolia ja domperidonia sisältävä kalvopäällysteinen tabletti
HU186855B (en) Process for producing galenic pharmaceutical compositions with controlled solving-out of active agents
JP2006001920A (ja) 医薬製剤
JPS5865215A (ja) 医薬組成物
US5260333A (en) Effect of a combination of a terbutaline, diphenhydramine and ranitidine composition on gastrointestinal injury produced by nonsteroidal anti-inflammatory compositions
CZ270999A3 (cs) Farmaceutické prostředky obsahující ibuprofen a domperidone pro ošetřování migrény
JPH08506808A (ja) 呼吸障害治療用組成物の製造における鎮痛剤s(+)対掌体の利用
RU2004131213A (ru) Лекарственные формы трамадола замедленного высвобождения
JPH11510168A (ja) 呼吸障害を処理するための鎮痛剤及び抗ヒスタミン剤を含有する組成物及び方法
US5998478A (en) Timed release tablet comprising naproxen and pseudoephedrine
GB2216413A (en) Medicaments containing sufotidine
JPS5855421A (ja) 医薬組成物
EP0017169A1 (en) Improved anti-inflammatory combinations having reduced ulcerogenicity
AU758880B2 (en) Timed release tablet comprising naproxen and pseudoephedrine
EP2682112A1 (en) Combined capsule formulations of flurbiprofen and famotidine